We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Stain-Free Imaging Platform Matches Standard Cancer Pathology

By LabMedica International staff writers
Posted on 16 Jun 2026

Histopathology underpins cancer diagnosis, but turnaround times and inter-laboratory variability can limit timely, consistent interpretation. More...

Conventional staining relies on chemical dyes and multiple preparation steps that add time and may affect image quality. A new study shows that a stain-free platform can generate diagnostic images comparable to standard staining while accelerating workflow and supporting algorithm development.

King Abdullah University of Science and Technology (KAUST; Thuwal, Saudi Arabia) has developed a stain-free imaging platform designed to analyze tissue samples more quickly and consistently. The approach replaces dyes with engineered silicon slides that produce detailed structural color images directly from tissue, enabling immediate microscopic assessment. The images are suitable for pathologist review and generate standardized digital data that could support future AI-assisted diagnosis.

The platform was first validated on colorectal tissue, a priority disease area in Saudi Arabia. In a head-to-head evaluation against conventional pathology, the stain-free method achieved 99% agreement in diagnostic conclusions for colorectal specimens. The study assessed tissue from 120 patients and found strong concordance in identifying healthy and cancerous features, while early results indicated a 40–50% reduction in sample preparation time compared with standard workflows.

The research is published in Advanced Science and aligns with KAUST’s Smart Health mission to advance technologies for cancer prevention, diagnosis, and treatment. KAUST is collaborating with King Faisal Specialist Hospital & Research Centre (KFSHRC) Madinah to further evaluate the platform across broader healthcare settings in Saudi Arabia. 

In addition to colorectal samples, tests on breast, lung, and thyroid tissues captured key histological features comparable to conventionally stained slides, supporting additional validation efforts. The team states the system was developed with practical deployment in mind and will continue to be assessed for clinical and commercial pathways.

“This research focuses on improving one of the most important steps in diagnosis: how tissue samples are prepared and reviewed,” said Qiaoqiang Gan, Professor of Material Science and Engineering at KAUST. “Traditional staining methods can be influenced by preparation steps, reagent quality, and laboratory conditions. By generating consistent digital images without dyes, we can reduce variability and create data that is more reliable for both clinical review and future AI-assisted analysis.”

Related Links
KAUST


Gold Member
Aspiration System
VACUSAFE
Online QC Software
Acusera 24•7
CMV CLIA Diagnostic
CLIA CMV IgA Screen Group
Automated Urinalysis Solution
UN-9000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: A new study identifies distinct metabolomic signatures in maternal blood associated with both the timing and type of early birth (Image credit: iStock)

Maternal Blood Biomarkers Identify Risk of Preterm and Early-Term Birth

Preterm and early-term births can lead to lasting complications because vital organs continue to mature during the final weeks of pregnancy. Babies born too soon face increased risks of breathing difficulties,... Read more

Microbiology

view channel
Image: Graphical Abstract (Emery, J. K., V. Nemidkanam, N. Colon, et al. Journal of Extracellular Vesicles (2026). https://doi.org/10.1002/jev2.70286)

Extracellular Vesicle Biomarker May Enable Noninvasive Monitoring of H. pylori

Helicobacter pylori infects an estimated 43.9% of the global population, affecting approximately 4.4 billion people worldwide. In many regions, including Africa, Eastern Europe, and Southeast Asia, prevalence... Read more

Industry

view channel
Image

QIAGEN Enhances QIAcuity Platform with Gene Expression and Multiplexing Tools

QIAGEN (Venlo, Netherlands) has introduced additions to its QIAcuity dPCR ecosystem that focus on gene expression, expanded assay content, and workflow standardization for life sciences and biopharma users.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.